Preliminary Scientific Program
We, the organizing committee are pleased to share the preliminary scientific program for Synuclein Meeting 2027, which will take place at Aarhus
University, Denmark, from May 25–28, 2027.
The Synuclein Meeting has been held regularly since 2007, and the 2027 edition will mark its 20th anniversary. Over the years, it has become a well-established forum for researchers interested in α-synuclein biology and the mechanisms underlying Parkinson's disease and related synucleinopathies.
The meeting covers all aspects of α-synuclein research, spanning structural and molecular studies, cellular and in vivo models, translational research, biomarkers, and clinical trials. We expect to host approximately 300–400 participants from academia, industry, the clinic and funding bodies.
The meeting will bring together leading experts, clinicians, translational researchers, and emerging investigators working on Parkinson's disease and related synucleinopathies: dementia with Lewy bodies (DLB) and multiple system atrophy (MSA).
The program will feature 13 thematic sessions with each session including:
Session Overview
Chair: Leonidas Stefanis
Special Feature: Round table discussion following presentations
Chair: Amanda Woerman
Chair: George Tofaris
Chair: Sreeganga S. Chandra
Chair: Friederike Zunke
Chair: Marina Romero-Ramos
Chair: Laura Parkkinen
Chair: Andy West
Chair: Laura Parkkinen
Chair: Nathalie Van Den Berge
Chair: Poul Henning Jensen
Invited Speakers
Chair: Maria Xilouri
Invited Speakers
Chair: TBC
Invited Speakers
Several companies will be invited to discus and present the latest compounds and trials.